Trulicity 0.75 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FRVBN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,722
Award facts
- Contract value 100% obligated
- $8,721.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,721.61, is for the supply of the diabetes medication Trulicity 0.75 mg/0.5 ml pen. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not set-aside and was open to full and open competition.
Quick answers
Who was awarded contract SPE2DB25FRVBN?
SPE2DB25FRVBN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 10, 2025.
How much is contract SPE2DB25FRVBN worth?
The government has obligated $8,722 on SPE2DB25FRVBN.
Is contract SPE2DB25FRVBN an order under another contract?
Yes. SPE2DB25FRVBN is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FRVBN competed?
The extent of competition for SPE2DB25FRVBN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award